CagReta (Reta+)
Price range: € 149,95 through € 199,95
CagReta (Reta+): a unique formula with Retatrivora and Cagrilintide in one vial or pen. For research involving GLP-1, GIP, glucagon and amylin receptor pathways.
Vial: BAC water and a set of syringe needles included.
Black pen: hardcase pen holder and a set of pen needles included.
For laboratory research only.
Batch Information
Discreet Packaging
EU Shipping
Secure Checkout
Product Information
Review product details, strength options and batch information before ordering.
CagReta (Reta+): unique formula, four receptor pathways
CagReta (Reta+) combines Retatrivora and Cagrilintide in one vial or pen. This unique formula brings together ingredients described in research in relation to four receptor pathways: GLP-1, GIP, glucagon and amylin.
Four receptor pathways explained
Retatrivora is being investigated as an agonist of the GLP-1, GIP and glucagon receptors. Cagrilintide is an amylin analogue with activity at amylin receptors. The information below describes the biological roles of these pathways; it does not establish the activity, safety or stability of this combined formula.
| Receptor pathway | Role in research |
|---|---|
| GLP-1 | Involved in glucose-dependent insulin signalling, gastric emptying and satiety signalling. |
| GIP | Involved in the response to nutrients, glucose-dependent insulin signalling and metabolism. |
| Glucagon | Involved in glucose release from the liver and the regulation of energy metabolism. |
| Amylin | Involved in satiety signalling, gastric emptying and the response to a meal. |
Choose vial or pen
Both presentations combine Retatrivora and Cagrilintide in the same unit. The vial includes BAC water and a set of syringe needles. The black pen includes a hardcase pen holder and a set of pen needles.
Product specifications
| Product | CagReta (Reta+) |
|---|---|
| Formula | Retatrivora + Cagrilintide |
| Ingredient receptor pathways | GLP-1, GIP, glucagon and amylin |
| Presentations | Vial or black pen; both ingredients combined in the same unit |
| Included with the vial | BAC water and a set of syringe needles |
| Included with the pen | Hardcase pen holder and a set of pen needles |
| Intended use | Laboratory research only |
Storage and documentation
Follow the supplied product label and documentation for storage conditions. Further product information and available documentation can be requested.
Product questions
Are both ingredients in the same vial or pen?
Yes. CagReta (Reta+) combines Retatrivora and Cagrilintide in one vial or pen.
Which four receptor pathways are referenced?
GLP-1, GIP, glucagon and amylin. This refers to the reported properties of the individual ingredients and does not establish clinical evidence for the combined product.
What is the difference between vial and pen?
The presentation and included accessories differ. The vial includes BAC water and a set of syringe needles. The black pen includes a hardcase pen holder and a set of pen needles.
For laboratory research only. Not for human or veterinary use, diagnosis or treatment.
Additional information
| Presentation | Vial, Pen |
|---|
Related Research Products
Explore other products in related research categories.
Related products
-
Retatrivora + Cagrilintide Bundle
Price range: € 179,95 through € 279,95 -
Sale!
Retatrivora 20 mg+ GHK-Cu 100 mgResearch Bundle
Original price was: € 159,50.€ 134,95Current price is: € 134,95. -
HGH Fragment 176-191 Research Peptide Vial – 5 mg
€ 39,95 -
Sale!
Retatrivora Multi-Vial Research Bundle – 3 × 20 mg
Original price was: € 319,50.€ 269,00Current price is: € 269,00.
Reviews
There are no reviews yet